Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00375804 · ClinicalTrials.gov registry record
Racial Disparity in Endometrial Cancer
A clinical trial, sponsored by University of Louisville.
- Terminated
- Registry status
- 43
- Enrollment target
NCT00375804 is a clinical trial that was terminated before completion, run by University of Louisville. The registered enrollment target is 43 participants.
The verdict
NCT00375804 was terminated before completion, sponsored by University of Louisville.
- TERMINATED
- Registry status
- 43 participants
- Enrollment target
Study Summary
The objectives for this study: 1. Investigate some of the causes for the racial disparity of endometrial cancer survival rates among black and white women 2. Examine the biologic correlates of aggressive behavior such as estrogen receptor status, p53 and HER-2/neu overexpression, and aromatase activity
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2003-06 |
| Est. Completion | 2010-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00375804
The ClinicalTrials.gov registry entry for NCT00375804 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Louisville, which has 217 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00375804 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00375804 about?
NCT00375804 is a clinical study titled "Racial Disparity in Endometrial Cancer". The objectives for this study: 1. Investigate some of the causes for the racial disparity of endometrial cancer survival rates among black and white women 2. Examine the biologic correlates of aggressive behavior such as estrogen receptor status, p53 and HER-2/neu overexpression, and aromatase acti...
What is the current status of trial NCT00375804?
This trial is currently terminated. The enrollment target is 43 participants. The study started on 2003-06. Estimated completion is 2010-06.
Who is sponsoring clinical trial NCT00375804?
This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.